Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
5.03(c) 5.06(c) 5.04(c) 4.685(c) 5.18 Last
243 704 85 805 128 799 426 585 410 019 Volume
-3.64% +0.60% -0.40% -7.04% +10.57% Change
More quotes
Estimated financial data (e)
Sales 2021 8,21 M 9,63 M 9,63 M
Net income 2021 -60,0 M -70,4 M -70,4 M
Net Debt 2021 16,1 M 18,9 M 18,9 M
P/E ratio 2021 -1,20x
Yield 2021 -
Sales 2022 38,8 M 45,5 M 45,5 M
Net income 2022 -42,4 M -49,7 M -49,7 M
Net Debt 2022 59,8 M 70,1 M 70,1 M
P/E ratio 2022 -1,73x
Yield 2022 -
Capitalization 144 M 169 M 168 M
EV / Sales 2021 19,4x
EV / Sales 2022 5,24x
Nbr of Employees 206
Free-Float 88,9%
More Financials
Company
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer.... 
More about the company
Ratings of ERYTECH Pharma S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ERYTECH PHARMA S.A.
10:52aERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conferenc..
PU
09/15ERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conferenc..
AQ
09/13European ADRs Rise 1% Monday as Energy Giants Gain, Pharma Retreats
MT
09/07GLOBAL MARKETS LIVE : Ryanair, Hyundai, Adecco, Goldman Sachs, JD.com...
09/06ERYTECH PHARMA S A : to Present at the H.C. Wainwright 23rd Annual Global Invest..
GL
09/03ERYTECH PHARMA S A : Webinar on Eryaspase in Pancreatic Cancer (September 1, 202..
PU
08/31GLOBAL MARKETS LIVE : EssilorLuxottica, PayPal, Volkswagen, Holcim, Apple....
08/30ERYTECH PHARMA S A : to Participate in the Citi 16th Annual BioPharma Conference
GL
08/25GLOBAL MARKETS LIVE : Kering, Delta Air Lines, Pfizer, Moderna, Sony...
08/25European ADRs Slightly Higher Wednesday Morning
MT
08/24ERYTECH PHARMA S A : Hosting Key Opinion Leader Webinar on Eryaspase in Pancreat..
GL
08/20European ADRs Move Higher in Friday Trading
MT
08/19European ADRs Down 1% Thursday Morning
MT
08/13European ADRs Move Higher in Friday Trading
MT
08/12European ADRs Move Lower in Thursday Trading
MT
More news
News in other languages on ERYTECH PHARMA S.A.
10:52aERYTECH PHARMA S A : tiendra un webcast le 21 septembre 2021 à l'occasion de ses..
09/13Les ADR européens progressent de 1 % lundi, les géants de l'énergie gagnent d..
09/07STOCK MARKET PARIS : L'Europe se reprend, l'Amérique se réveille, l'Asie se rebi..
09/07EN DIRECT DES MARCHES : Engie, EDF, Valeo, ALD, McPhy, Ryanair, Allianz, Partner..
09/06ERYTECH PHARMA S A : tiendra une présentation à la H.C. Wainwright 23rd Annual G..
More news
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | ERYP | FR0011471135 | MarketScreener
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 4,69 €
Average target price 14,50 €
Spread / Average Target 209%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-34.11%153
BIONTECH SE357.13%90 003
GILEAD SCIENCES, INC.22.43%89 434
REGENERON PHARMACEUTICALS35.20%67 910
WUXI APPTEC CO., LTD.35.75%65 728
VERTEX PHARMACEUTICALS-20.83%48 539